Federal Register / Vol. 87, No. 30 / Monday, February 14, 2022 / Notices 8261 

Management Lead, National Center for 

HIV, Viral Hepatitis, STD, and TB 

Prevention, CDC, 1600 Clifton Road NE, 

Mailstop US8–6, Atlanta, Georgia 

30329–4027, Telephone: (404) 639– 

3423; Email: MCondit@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Nominations are being sought for 

persons who have expertise and 

qualifications necessary to contribute to 

the accomplishments of the council’s 

objectives. Nominees will be selected on 

the basis of their expertise in public 

health, epidemiology, immunology, 

infectious diseases, pulmonary disease, 

pediatrics, tuberculosis, microbiology, 

or preventive health care delivery. 

Federal employees will not be 

considered for membership. Members 

may be invited to serve for up to fouryear terms. 

Selection of members is based on 

candidates’ qualifications to contribute 

to the accomplishment of ACET 

objectives. 

The U.S. Department of Health and 

Human Services policy stipulates that 

committee membership be balanced in 

terms of points of view represented and 

the committee’s function. Appointments 

shall be made without discrimination 

on the basis of age, race, ethnicity, 

gender, sexual orientation, gender 

identity, HIV status, disability, and 

cultural, religious, or socioeconomic 

status. Nominees must be U.S. citizens 

and cannot be full-time employees of 

the U.S. Government. Current 

participation on federal workgroups or 

prior experience serving on a federal 

advisory committee does not disqualify 

a candidate; however, HHS policy is to 

avoid excessive individual service on 

advisory committees and multiple 

committee memberships. Committee 

members are Special Government 

Employees (SGEs), requiring the filing 

of financial disclosure reports at the 

beginning and annually during their 

terms. CDC reviews potential candidates 

for ACET membership each year and 

provides a slate of nominees for 

consideration to the Secretary of HHS 

for final selection. HHS notifies selected 

candidates of their appointment near 

the start of the term in July 2023, or as 

soon as the HHS selection process is 

completed. Note that the need for 

different expertise varies from year to 

year and a candidate who is not selected 

in one year may be reconsidered in a 

subsequent year. SGE nominees must be 

U.S. citizens and cannot be full-time 

employees of the U.S. Government. 

Candidates should submit the following 

items to be considered: 

D Current curriculum vitae, including 

complete contact information 

(telephone numbers, mailing address, 

and email address). 

D At least one letter of 

recommendation from person(s) not 

employed by the U.S. Department of 

Health and Human Services. Candidates 

may submit letter(s) from current HHS 

employees if they wish, but at least one 

letter must be submitted by a person not 

employed by an HHS agency (i.e., CDC, 

NIH, FDA, etc.). 

Nominations may be submitted by the 

candidate himself or herself or by a 

person or organization recommending 

the candidate. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–03036 Filed 2–11–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–22–1132; Docket No. CDC–2022– 

0023] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled Performance Progress and 

Monitoring Report (PPMR). The PPMR 

is designed to allow CDC to collect 

information related to CDC Awardee’s 

budgets, strategies and activities, and 

the process and outcome performance 

measures outlined by the cooperative 

agreement programs, in order to 

evaluate partnerships and the work that 

is done on behalf of CDC. 

DATES: CDC must receive written 

comments on or before April 15, 2022. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2022– 

0023 by either of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 


jspears on DSK121TN23PROD with NOTICES1
8262 Federal Register / Vol. 87, No. 30 / Monday, February 14, 2022 / Notices 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

Performance Progress and Monitoring 

Report (PPMR) (OMB Control No. 0920– 

1132, Exp. 10/31/2022)—Extension— 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

Each year, approximately 80% of the 

CDC’s budget is distributed via 

contracts, grants and cooperative 

agreements, from the Office of Financial 

Resources (OFR) to partners (Awardees) 

throughout the world in an effort to 

promote health, prevent disease, injury 

and disability and prepare for new 

health threats. OFR is responsible for 

the stewardship of these funds while 

providing excellent, professional 

services to our partners and 

stakeholders. 

Currently, CDC uses the Performance 

Progress and Monitoring Report (PPMR, 

OMB Control No. 0920–1132, 

Expiration: 10/31/2022), a set of 

progress reporting forms for NonResearch awards to collect information 

semi-annually from Awardees regarding 

the progress made over specified time 

periods on CDC funded projects. The 

PPMR was originally modified from SF– 

PPR (OMB Control No. 0970–0406, 

Expiration: 10/31/2015), a similar 

progress report that was owned by the 

Administration for Children and 

Families (ACF) within the Department 

of Health and Human Services (HHS). 

The PPMR was created by CDC to 

provide an agency-wide collection tool 

that would be able to obtain data on the 

progress of CDC Awardees for the 

purposes of evaluation, and to bring the 

Awardee reporting procedure into 

compliance with the Paperwork 

Reduction Act (PRA). 

The information collected enables the 

accurate, reliable, uniform, and timely 

submission to CDC of each Awardee’s 

work plans and progress reports, 

including strategies, activities and 

performance measures. The information 

collected by the PPMR is designed to 

align with, and support the goals 

outlined for each of the CDC Awardees. 

Collection and reporting of the 

information will occur in an efficient, 

standardized, and user-friendly manner 

that will generate a variety of routine 

and customizable reports. The PPMR 

will allow each Awardee to summarize 

activities and progress towards meeting 

performance measures and goals over a 

specified time period specific to each 

award. CDC will also have the capacity 

to generate reports that describe 

activities across multiple Awardees. In 

addition, CDC will use the information 

collection to respond to inquiries from 

HHS, Congress and other stakeholder 

inquiries about program activities and 

their impact. The current submission 

process allows Awardees to submit a 

completed PDF version of the PPMR by 

uploading it to www.grants.gov, or 

directly to the programs at CDC that will 

be performing the evaluation. 

This Extension request is being 

submitted to allow CDC to continue 

collection of this valuable information 

from Awardees for an additional three 

years. There are no anticipated changes 

to the information collection 

instruments or associated burden at this 

time. CDC requests OMB approval for an 

estimated 13,014 annual burden hours. 

There is no cost to respondents other 

than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

CDC Award Recipients ..................... Performance Progress and Monitoring Report (PPMR—Att. A–F).5,200 1 2 10,400 

CDC Award Recipients ..................... Performance Progress and Monitoring Report (PPMR—Att. G).1,632 1 5/60 136 

NHSS Award Recipients ................... Performance Progress and Monitoring Report (PPMR—Att. A–F).60 1 41 2,478 

Total ........................................... ........................................................... ........................ ........................ ........................ 13,014 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2022–03080 Filed 2–11–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2022–N–0083] 

Food and Drug Administration Hiring 

and Retention Final Assessment; 

Public Meeting; Request for Comments 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of public meeting; 

request for comments. 

SUMMARY: The Food and Drug 

Administration (FDA, the Agency, or 

we) is holding a virtual meeting entitled 

‘‘FDA Hiring and Retention Final 

Assessment’’ and an opportunity for 

public comment. The topic to be 

discussed is the FDA Hiring and 

Retention Final Assessment, which was 

an independent assessment performed 

by Booz Allen Hamilton, published on 

December 10, 2021. This public meeting 

will take place virtually due to 

extenuating circumstances and will be 

held by webcast only. 

DATES: The public meeting will be held 

on March 15, 2022, from 9 a.m. to 12 

noon Eastern Time. Submit either 

electronic or written comments on this 

public meeting by May 16, 2022. See the 


jspears on DSK121TN23PROD with NOTICES1